948.45 USD
↘ 26.51 (2.72%)AT CLOSE (11:59 AM EDT)
Eli Lilly & Co.
LLYNYSE • USD
950.10
↗ 1.65 (0.17%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
950.10
↗ 1.65 (0.17%)
Market: CLOSED
Open?$974.07
High?$980.00
Low?$947.51
Prev. Close?$974.96
Volume?3.6M
Avg. Volume?3.2M
VWAP?$955.53
Rel. Volume?1.10x
Bid / Ask
Bid?$949.80 × 40
Ask?$950.60 × 40
Spread?$0.80
Midpoint?$950.20
Valuation & Ratios
Market Cap?869.4B
Shares Out?944.8M
Float?851.3M
Float %?90.1%
P/E Ratio?34.40
P/B Ratio?27.87
EPS?$28.35
Dividend?0.64%
Ex-Dividend?2026-05-15
News
Profile
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Themes
Employees
50.0K
Market Cap
869.4B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1970-07-09
Address
LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.50Adequate
Quick Ratio?1.10Adequate
Cash Ratio?0.14Low
Debt/Equity?1.39Moderate
ValuationRICHLY VALUED
Score33/100
P/E?34.4PRICEY▾
P/B?27.87HIGH▾
P/S?12.03HIGH▾
P/FCF?73.5PRICEY▾
EV/EBITDA?25.1HIGH▾
EV/Sales?12.56HIGH▾
Returns & Efficiency
ROE?81.0%STRONG▾
ROA?21.7%STRONG▾
Cash Flow & Enterprise
FCF?$11.8B
Enterprise Value?$907.5B
Fundamentals ratios updated end of day